- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 14 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 20 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 2 residues within 4Å:- Chain A: N.158, K.169
No protein-ligand interaction detected (PLIP)NAG-NAG.5: 3 residues within 4Å:- Chain A: N.274, T.276, N.277
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:N.277
NAG-NAG.6: 4 residues within 4Å:- Chain A: E.291, N.293, N.329
- Ligands: NAG-NAG-BMA.8
No protein-ligand interaction detected (PLIP)NAG-NAG.7: 2 residues within 4Å:- Chain A: N.299, I.320
No protein-ligand interaction detected (PLIP)NAG-NAG.9: 4 residues within 4Å:- Chain A: R.332, N.336, K.340, W.391
No protein-ligand interaction detected (PLIP)NAG-NAG.12: 1 residues within 4Å:- Chain A: N.388
No protein-ligand interaction detected (PLIP)NAG-NAG.15: 5 residues within 4Å:- Chain B: V.134, N.154, K.169, Y.171, L.173
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:K.169
NAG-NAG.16: 2 residues within 4Å:- Chain B: N.158, Q.168
No protein-ligand interaction detected (PLIP)NAG-NAG.17: 4 residues within 4Å:- Chain B: V.85, N.227, K.229, N.239
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:V.85
NAG-NAG.19: 4 residues within 4Å:- Chain B: E.291, N.293, R.436
- Ligands: NAG-NAG-BMA.21
No protein-ligand interaction detected (PLIP)NAG-NAG.24: 1 residues within 4Å:- Chain B: N.388
No protein-ligand interaction detected (PLIP)NAG-NAG.25: 3 residues within 4Å:- Chain B: R.250, N.440
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.18
No protein-ligand interaction detected (PLIP)NAG-NAG.26: 2 residues within 4Å:- Chain B: N.603, S.605
No protein-ligand interaction detected (PLIP)NAG-NAG.27: 3 residues within 4Å:- Chain B: R.625, E.626, N.629
No protein-ligand interaction detected (PLIP)NAG-NAG.29: 3 residues within 4Å:- Chain C: N.158, V.167, K.169
No protein-ligand interaction detected (PLIP)NAG-NAG.32: 2 residues within 4Å:- Chain C: N.293
- Ligands: NAG-NAG-BMA.34
No protein-ligand interaction detected (PLIP)NAG-NAG.33: 2 residues within 4Å:- Chain C: N.299, I.320
No protein-ligand interaction detected (PLIP)NAG-NAG.35: 2 residues within 4Å:- Chain C: N.358, R.461
No protein-ligand interaction detected (PLIP)NAG-NAG.39: 2 residues within 4Å:- Chain C: N.603, S.605
No protein-ligand interaction detected (PLIP)NAG-NAG.40: 1 residues within 4Å:- Chain C: N.629
No protein-ligand interaction detected (PLIP)- 2 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN-MAN.4: 13 residues within 4Å:- Chain A: S.207, E.209, P.210, R.250, N.260, N.373, C.374, G.375, I.431, R.436, C.437, S.438, S.439
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:G.375, A:S.438
NAG-NAG-BMA-MAN-MAN-MAN-MAN.18: 17 residues within 4Å:- Chain B: E.64, S.207, R.250, L.259, N.260, R.302, N.373, C.374, I.431, R.432, G.433, I.435, R.436, C.437, S.438, S.439
- Ligands: NAG-NAG.25
No protein-ligand interaction detected (PLIP)- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 7 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.41: 2 residues within 4Å:- Chain A: E.87, N.88
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:E.87
- Hydrogen bonds: A:E.87
NAG.42: 2 residues within 4Å:- Chain A: V.134, N.135
No protein-ligand interaction detected (PLIP)NAG.43: 1 residues within 4Å:- Chain A: N.629
No protein-ligand interaction detected (PLIP)NAG.45: 1 residues within 4Å:- Chain B: N.608
No protein-ligand interaction detected (PLIP)NAG.46: 1 residues within 4Å:- Chain B: N.617
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.617
NAG.48: 3 residues within 4Å:- Chain C: R.347, N.352, N.393
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:N.393
- Hydrogen bonds: C:N.352
NAG.49: 1 residues within 4Å:- Chain C: N.617
No protein-ligand interaction detected (PLIP)- 3 x 83G: 1-[(2R)-4-(benzenecarbonyl)-2-methylpiperazin-1-yl]-2-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)ethane-1,2-dione(Non-covalent)
83G.44: 14 residues within 4Å:- Chain A: I.109, W.112, D.113, L.116, V.253, S.371, F.378, I.416, N.417, M.418, W.419, K.424, A.425, M.467
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:W.112, A:V.253, A:F.378, A:F.378, A:W.419
- Hydrogen bonds: A:W.419, A:Q.420, A:K.424
83G.47: 14 residues within 4Å:- Chain B: I.109, W.112, V.253, S.371, N.373, F.378, Y.380, I.416, N.417, M.418, W.419, K.424, M.426, M.467
9 PLIP interactions:9 interactions with chain B- Hydrophobic interactions: B:W.112, B:V.253, B:F.378, B:F.378, B:I.416, B:W.419, B:W.419, B:M.426
- Hydrogen bonds: B:W.419
83G.50: 16 residues within 4Å:- Chain C: I.109, W.112, D.113, V.252, V.253, S.254, E.366, S.371, N.373, I.416, N.417, M.418, W.419, K.424, A.425, M.426
5 PLIP interactions:5 interactions with chain C- Hydrophobic interactions: C:W.112, C:V.253, C:V.253, C:M.426
- pi-Stacking: C:W.419
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, S. et al., Asymmetric Structures and Conformational Plasticity of the Uncleaved Full-Length Human Immunodeficiency Virus Envelope Glycoprotein Trimer. J.Virol. (2021)
- Release Date
- 2021-09-22
- Peptides
- Envelope glycoprotein gp160: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 14 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 20 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 7 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x 83G: 1-[(2R)-4-(benzenecarbonyl)-2-methylpiperazin-1-yl]-2-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)ethane-1,2-dione(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, S. et al., Asymmetric Structures and Conformational Plasticity of the Uncleaved Full-Length Human Immunodeficiency Virus Envelope Glycoprotein Trimer. J.Virol. (2021)
- Release Date
- 2021-09-22
- Peptides
- Envelope glycoprotein gp160: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C